139 related articles for article (PubMed ID: 23756577)
1. A door opener for future research: agonist-induced β3-adrenoceptor desensitization in HEK cells but not CHO cells.
Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 2013 Oct; 386(10):841-2. PubMed ID: 23756577
[No Abstract] [Full Text] [Related]
2. Agonist-induced desensitization of human β3-adrenoceptors expressed in human embryonic kidney cells.
Michel-Reher MB; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 2013 Oct; 386(10):843-51. PubMed ID: 23756578
[TBL] [Abstract][Full Text] [Related]
3. Mirabegron, a β
Mendes-Silvério CB; Alexandre EM; Lescano CH; Antunes E; Mónica FZ
Eur J Pharmacol; 2018 Jun; 829():79-84. PubMed ID: 29654782
[TBL] [Abstract][Full Text] [Related]
4. Human β3-Adrenoreceptor is Resistant to Agonist-Induced Desensitization in Renal Epithelial Cells.
Milano S; Gerbino A; Schena G; Carmosino M; Svelto M; Procino G
Cell Physiol Biochem; 2018; 48(2):847-862. PubMed ID: 30032151
[TBL] [Abstract][Full Text] [Related]
5. β
Fong Z; Griffin CS; Hollywood MA; Thornbury KD; Sergeant GP
Am J Physiol Cell Physiol; 2019 Jul; 317(1):C131-C142. PubMed ID: 31042424
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of the combination of KPR-5714, a novel transient receptor potential melastatin 8 (TRPM8) antagonist, and β
Aizawa N; Fujimori Y; Nakanishi O; Hayashi T; Goi Y; Kobayashi JI; Fujita T
Eur J Pharmacol; 2021 May; 899():173995. PubMed ID: 33675781
[TBL] [Abstract][Full Text] [Related]
7. The odd sibling: features of β3-adrenoceptor pharmacology.
Cernecka H; Sand C; Michel MC
Mol Pharmacol; 2014 Nov; 86(5):479-84. PubMed ID: 24890609
[TBL] [Abstract][Full Text] [Related]
8. Modulatory effect of the adrenergic system upon fibroblast proliferation: participation of beta 3-adrenoceptors.
Anesini C; Borda E
Auton Autacoid Pharmacol; 2002 Jun; 22(3):177-86. PubMed ID: 12452903
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo pharmacological profile of the selective β3-adrenoceptor agonist mirabegron in rats.
Hatanaka T; Ukai M; Watanabe M; Someya A; Ohtake A; Suzuki M; Ueshima K; Sato S; Sasamata M
Naunyn Schmiedebergs Arch Pharmacol; 2013 Mar; 386(3):247-53. PubMed ID: 23239087
[TBL] [Abstract][Full Text] [Related]
10. Desirable properties of β3-adrenoceptor agonists: implications for the selection of drug development candidates.
Michel MC; Cernecka H; Ochodnicky P
Eur J Pharmacol; 2011 Apr; 657(1-3):1-3. PubMed ID: 21315709
[TBL] [Abstract][Full Text] [Related]
11. The β3-adrenoceptor mediates the inhibitory effects of β-adrenoceptor agonists via the urothelium in pig bladder dome.
Masunaga K; Chapple CR; McKay NG; Yoshida M; Sellers DJ
Neurourol Urodyn; 2010 Sep; 29(7):1320-5. PubMed ID: 20151470
[TBL] [Abstract][Full Text] [Related]
12. Agonist-induced desensitisation of β
Okeke K; Angers S; Bouvier M; Michel MC
Br J Pharmacol; 2019 Jul; 176(14):2539-2558. PubMed ID: 30809805
[TBL] [Abstract][Full Text] [Related]
13. Effects of beta3-adrenoceptor activation on the interaction between adrenoceptors and angiotensin II receptors in apolipoprotein E knockout mouse lung.
Jiang ZL; Li YF; Song JY; Guo YQ
Eur J Pharmacol; 2014 Nov; 742():75-80. PubMed ID: 25220245
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cholinergic neurotransmission by β
Silva I; Costa AF; Moreira S; Ferreirinha F; Magalhães-Cardoso MT; Calejo I; Silva-Ramos M; Correia-de-Sá P
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F388-F403. PubMed ID: 28446460
[TBL] [Abstract][Full Text] [Related]
15. Effects of β(3)-adrenoceptor activation on expression of pancreatic adrenoceptors and angiotensin II receptors in ApoE(-/-) mice.
Song JY; Li YF; Zhi-Li J; Guo YQ
Eur J Pharmacol; 2015 Oct; 764():134-139. PubMed ID: 26102566
[TBL] [Abstract][Full Text] [Related]
16. Aucubin protects against pressure overload-induced cardiac remodelling via the β
Wu QQ; Xiao Y; Duan MX; Yuan Y; Jiang XH; Yang Z; Liao HH; Deng W; Tang QZ
Br J Pharmacol; 2018 May; 175(9):1548-1566. PubMed ID: 29447430
[TBL] [Abstract][Full Text] [Related]
17. Incontinence: How do β
Igawa Y; Aizawa N
Nat Rev Urol; 2017 Jun; 14(6):330-332. PubMed ID: 28322259
[No Abstract] [Full Text] [Related]
18. β
Cao X; Li Y
J Clin Lipidol; 2017; 11(5):1168-1176. PubMed ID: 28802864
[TBL] [Abstract][Full Text] [Related]
19. β
Igawa Y; Aizawa N; Michel MC
Br J Pharmacol; 2019 Jul; 176(14):2525-2538. PubMed ID: 30868554
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide production from rat adipocytes is modulated by beta3-adrenergic receptor agonists and is involved in a cyclic AMP-dependent lipolysis in adipocytes.
Canová NK; Lincová D; Kmonícková E; Kameníková L; Farghali H
Nitric Oxide; 2006 May; 14(3):200-11. PubMed ID: 16413212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
